Neptune Medical earns FDA clearance for its Triton 1 robotic system

Neptune Medical Inc. this week introduced FDA clearance for its Triton 1 System. The comapny stated it designed the robotic for versatile endoscopy and for diagnostic and therapeutic procedures all through the colon.

Triton can carry robotic precision, stability, and management to succeed in the complete colon, claimed Neptune Medical. The Burlingame, Calif.-based company stated the system can elevate any endoscopist’s capabilities for screening, surveillance, and diagnostic colonoscopies, in addition to different extra advanced procedures within the colon. These embody endoscopic mucosal resections (EMRs) and endoscopic submucosal dissections (ESDs).

“Triton has the potential to basically rework colonoscopy, creating a greater expertise for each physicians and their sufferers. Attaining regulatory clearance within the U.S. brings us one step nearer to that actuality,” said Alex Tilson, founder and CEO of Neptune Medical. “We’re utilizing this technology of the Triton system to construct on the proof from our current trial and to be taught from endoscopists how robotics ought to combine into their workflow — insights that can straight form our next-generation platform.”

Triton tech aids prognosis of widespread most cancers

Colorectal most cancers is the second main reason behind most cancers demise within the U.S. and more and more impacts adults underneath age 50. Colonoscopy is the gold commonplace for the prognosis, prevention and remedy of colorectal most cancers, as it’s the solely process that enables for each detection and removing of precancerous lesions in a single session, in response to Neptune.

Nonetheless, in the present day’s endoscopes have inherent design limitations that make them tough to manage regardless of gastroenterologists (GIs) present process years of specialised coaching, the corporate stated. Endoscope instability can result in incomplete visualization of the colon, missed adenomas (pre-cancerous lesions), and in the end, an elevated danger of most cancers growth.

In 2024, Neptune Medical raised $97 million in Collection D funding and launched its subsidiary Jupiter Endovascular Inc. The shift allowed Jupiter Endovascular to focus by itself expertise platform, stated the businesses.

Register now and assist us rejoice 20 years of RoboBusiness!

Neptune will get outcomes from Triton’s first in-human examine

Neptune Medical offered its first-in-human CARE 1 examine earlier this 12 months. The examine confirmed that the Triton 1 System met its major endpoints, with no hostile occasions and 100% cecal intubation.

The robotic system additionally demonstrated a excessive adenoma detection fee (ADR) of 54.2%, in contrast with the business threshold of 35%, the corporate reported. It was additionally efficient in making a extremely favorable ergonomic setting for endoscopists, with a 67% decrease common burden in comparison with handbook colonoscopy (primarily based on the NASA-TLX rating) and no affected person repositioning, belly strain, or conversion to handbook colonoscopy.

“Bringing robotics to decrease GI procedures is an thrilling prospect for us,” stated Jason B. Samarasena, M.D., chief of the Division of Gastroenterology and Hepatology at College of California, Irvine who was a part of Neptune’s CARE 1 medical trial. “Triton confirmed us the potential of one system that may display and deal with wherever within the colon, effectively, completely, and with minimal burden. I sit up for taking part in further medical analysis of the system that can assist its progress alongside the trail to commercialization.”

The publish Neptune Medical earns FDA clearance for its Triton 1 robotic system appeared first on The Robotic Report.